Quality standards and benchmarks in drug demand reduction

The Justice, Freedom and Security Directorate General from the European Commission has published on the 11th november a call for tender to study on the development of an EU framework for minimum quality standards and benchmarks in drug demand reduction.

The tender was published in the Official Journal, on the 11th november. It has the following scope:

  1. To conduct an inventory of existing (minimum) quality standards and benchmarks at national, EU and — when relevant — international level for the various types of demand-reduction interventions (drug prevention, early detection and screening, early intervention and treatment, harm reduction, rehabilitation and reintegration).
  2. To develop a workable design for a realistic, feasible and scientifically-robust framework for EU minimum quality standards and benchmarks in the most important areas of drug demand reduction as listed above. The framework should cover key aspects for each of the targeted areas, including — 'inter alia' — conditions for overall demand-reduction policies, the content of programmes and interventions, modes of planning and delivery, principles for monitoring and evaluation, etc.
  3. To establish a framework for an effective consultation and advisory mechanism necessary for consensus building among experts and relevant stakeholders from Member States and EU level. This is necessary to ensure transparency and active involvement of stakeholders to create advocacy for the development and adoption of EU minimum quality standards and benchmarks in drug demand reduction.



Enterprises or organisations wishing to participate in the tendering process must submit their proposal before the 15 december 2009 at the following address:
European Commission, Justice, Freedom and Security DG — Unit JLS/D/4
Attn: Renatas Mazeika
MO59 01/068
1049 Brussels

Tel. +32 22962152
faxFax +32 22979585
E-mail: JLS-D4-CFT@ec.europa.eu